Trump accused India of maintaining some of the “most strenuous and annoying non-monetary trade barriers” and of running a “massive” trade surplus with the US.
The decision has drawn the rupid, in which he has posted his steepest one -day decrease since May and reached a five -month low on Wednesday.
What the American rate means for the Indian markets
Nilesh Shah, MD at Kotak Mahindra AMC, called the tariff movement a clear negative for the markets. “Despite unpredictable American policy movements, markets expected that a tar love would ultimately train, because long-term strategic interests were matched in the US india,” he said. He hopes that cooler heads will prevail and that a “taco” (trade agreement on competitive offers) could still make the deal if both sides reflect their red lines.
However, Shah also gave a warning memorandum and urged India to take this moment to speed up internal reforms that improve competitiveness.
“Our biggest deterrence remains our GDP size and productivity. China defends American pressure because of scale and competitiveness. India must learn from that.”
India and the US had opened broad commercial conversations earlier this year, hoping that a deal could be signed in mid -2025. However, disagreements about market access, especially in agriculture and dairy products, held negotiations.
Trump has often used rates as a bone instrument to force compliance – a playbook that he seems to return to with renewed zeal. If he continues to tighten the screws, India can be forced to calibrate his trade strategy not only with the US, but also worldwide.
According to Garima Kapoor, EVP in Elara Capital, the new rate India brings in a disadvantage against export competitors such as Vietnam, Indonesia and the Philippines, who continue to enjoy lower rates on the American market.
If pharmaceutical products are included in the tariff films, the damage can be considerable. The US accounts for more than 30% of India’s Pharma export, making it an important pillar of the outer trade of India.
The lack of clarity about whether pharmaceutical and high-quality goods such as auto-components and steel are taxed uniform is the unrest of the market.
Kapoor warns that if a trading deal is not reached in September or October, the GDP growth of India could see a downward revision of at least 20 basic points. However, she notes that the delay can be a disguised blessing.
“A hotchpotch deal that has given too much to agriculture and dairy products could have had a far-reaching political and social costs. A well-negotiated deal, even if they are delayed, is preferred,” she said.
“The rate (and the fine) that is now proposed by the US is higher than what we had expected, and will therefore probably be a headwind for the GDP growth of India. The size of the disadvantage will depend on the size of the fines imposed,” said Aditi Nayar, chapter.
All in all, experts say that the market will have to live with volatility and the hope that this pressure will lead to a deal.
(Disclaimer: recommendations, suggestions, views and opinions of the experts are their own. These do not represent the views of economic times)
#Trumps #rate #rattles #handy #futures #bad #news #Indian #stock #market